Atlas Trials

Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours

Clinical trial NCT00697879 · COMPLETED

Trial details

NCT number
NCT00697879
Sponsor
Chroma Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2008-02-01
Primary completion
2010-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.